Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824-1317, United States.
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824-1317, United States.
Vascul Pharmacol. 2018 Jul;106:37-45. doi: 10.1016/j.vph.2018.02.004. Epub 2018 Feb 15.
Renal sympathetic activity affects blood pressure in part by increasing renovascular resistance via release of norepinephrine (NE) from sympathetic nerves onto renal arteries. Here we test the idea that adipose tissue adjacent to renal blood vessels, i.e. renal perivascular adipose tissue (RPVAT), contains a pool of NE which can be released to alter renal vascular function. RPVAT was obtained from around the main renal artery/vein of the male Sprague Dawley rats. Thoracic aortic PVAT and mesenteric PVAT also were studied as brown-like and white fat comparators respectively. RPVAT was identified as a mix of white and brown adipocytes, because of expression of both brown-like (e.g. uncoupling protein 1) and white adipogenic genes. All PVATs contained NE (ng/g tissue, RPVAT:524 ± 68, TAPVAT:740 ± 16, MPVAT:96 ± 24). NE was visualized specifically in RPVAT adipocytes by immunohistochemistry. The presence of RPVAT (+RPVAT) did not alter the response of isolated renal arteries to NE compared to responses of arteries without RPVAT (-RPVAT). By contrast, the maximum contraction to the sympathomimetic tyramine was ~2× greater in the renal artery +PVAT versus -PVAT. Tyramine-induced contraction in +RPVAT renal arteries was reduced by the α-adrenoceptor antagonist prazosin and the NE transporter inhibitor nisoxetine. These results suggest that tyramine caused release of NE from RPVAT. Renal denervation significantly (>50%) reduced NE content of RPVAT but did not modify tyramine-induced contraction of +RPVAT renal arteries. Collectively, these data support the existence of a releasable pool of NE in RPVAT that is independent of renal sympathetic innervation and has the potential to change renal arterial function.
肾交感神经活动通过从交感神经释放去甲肾上腺素(NE)到肾动脉来增加肾血管阻力,从而部分影响血压。在这里,我们检验了一个想法,即紧邻肾血管的脂肪组织,即肾血管周围脂肪组织(RPVAT),含有可以释放的 NE 池,从而改变肾血管功能。从雄性 Sprague Dawley 大鼠的主肾动静脉周围获得 RPVAT。胸主动脉 PVAT 和肠系膜 PVAT 也分别作为棕色样和白色脂肪的比较器进行了研究。由于表达棕色样(如解偶联蛋白 1)和白色脂肪生成基因,RPVAT 被鉴定为白色和棕色脂肪细胞的混合物。所有 PVAT 均含有 NE(ng/g 组织,RPVAT:524±68,TAPVAT:740±16,MPVAT:96±24)。免疫组织化学特异性显示 RPVAT 中的 NE。与无 RPVAT(-RPVAT)的动脉相比,存在 RPVAT(+RPVAT)并未改变分离的肾动脉对 NE 的反应。相比之下,在肾动脉+PVAT 中,对拟交感神经的酪胺的最大收缩作用比 -PVAT 约大 2 倍。在+RPVAT 肾动脉中,α-肾上腺素能受体拮抗剂哌唑嗪和 NE 转运蛋白抑制剂去甲西汀可降低酪胺引起的收缩。这些结果表明,酪胺引起 RPVAT 中 NE 的释放。肾去神经显著(>50%)降低了 RPVAT 的 NE 含量,但并未改变+RPVAT 肾动脉中酪胺诱导的收缩。综上所述,这些数据支持 RPVAT 中存在可释放的 NE 池,该池独立于肾交感神经支配,并有改变肾动脉功能的潜力。